RGNX

NASDAQStock

REGENXBIO Inc.

$8.47-0.61 (-6.72%)

52-Week Range

$5.31

$15.98

Key Stats

Market Cap

428.8M

P/E Ratio

—

Dividend Yield

—

Beta

1.14

Volume

807.6K

Avg Volume

1.0M

Performance

+8.74%

-34.35%

-0.11%

YTD

-33.09%

+35.12%

-56.37%

-78.26%

Price Chart

ETF Exposure

RGNX is held by 85 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVSU	Avantis Responsible U.S. Equity ETF	0.00%	1,462	$14K	$412.5M	0.15%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	117,172	$1.1M	$40.55B	0.17%
DXUV	Dimensional - US Vector Equity ETF	0.00%	1,300	$12K	$351.7M	0.28%
SMMD	iShares Russell 2500 ETF	0.00%	16,781	$157K	$2.28B	0.23%
AVUS	Avantis U.S. Equity ETF	0.00%	13,610	$196K	$10.96B	0.15%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	4,755	$43K	$2.68B	0.14%
HDG	ProShares - Hedge Replication ETF	0.00%	52	$472	$23.2M	0.95%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	10,006	$91K	$10.37B	0.12%
DFUS	Dimensional - US Equity Market ETF	0.00%	20,910	$190K	$18.51B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	96,830	$908K	$80.22B	0.03%
SCHB	Schwab U.S. Broad Market ETF	0.00%	25,000	$231K	$37.50B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	3,625	$40K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,428,039	$15.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,511	$114K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	647	$10K	$1.29B	0.17%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	96,830	$22K	$3.91B	0.07%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	4	$36	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	13	$121	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	22	$207	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	25	$238	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	30	$282	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	25	$235	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	17	$155	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	13	$117	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	6	$52	$9.3M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	9,324	$87K	$17.30B	0.20%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	770	$10K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	770	$10K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	770	$10K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	70	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,508	$38K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	770	$10K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	770	$10K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$183	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	96,830	$71K	$14.63B	0.20%

PreviousPage 2 of 2

About RGNX ETF Exposure

REGENXBIO Inc. (RGNX) is held by 85 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 428.8M, RGNX is a widely held institutional stock. The stock currently trades at $8.47. Investors can gain exposure to RGNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RGNX, sorted by portfolio weight.